B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Imatinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Imatinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

nilotinib
42 shared targets
masitinib
22 shared targets
cep
21 shared targets
raf
25 shared targets
ponatinib
25 shared targets
motesanib
20 shared targets
doramapimod
28 shared targets
pazopanib
31 shared targets
glesatinib
15 shared targets
dasatinib
16 shared targets
Loading evidence profile...

This evidence profile for Imatinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.